prednisolone has been researched along with POEMS Syndrome in 28 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
POEMS Syndrome: A multisystemic disorder characterized by a sensorimotor polyneuropathy (POLYNEUROPATHIES), organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension (HYPERTENSION, PULMONARY); cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. (From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18(7):553-62)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 57-year-old woman with Crow-Fukase syndrome presented thiamine deficiency and pulmonary hypertension of unknown etiology." | 7.69 | Thiamine deficiency and pulmonary hypertension in Crow-Fukase syndrome. ( Gohma, I; Hatta, K; Imanaka, T; Okura, H, 1995) |
| "POEMS syndrome is a rare paraneoplastic condition associated to an underlying plasmacellular dyscrasia." | 5.38 | Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. ( Balducci, M; Chiusolo, P; De Stefano, V; Giannotta, C; Laurenti, L; Leone, G; Luigetti, M; Sabatelli, M; Sica, S; Sorà, F; Vannata, B, 2012) |
| "A 57-year-old woman with Crow-Fukase syndrome presented thiamine deficiency and pulmonary hypertension of unknown etiology." | 3.69 | Thiamine deficiency and pulmonary hypertension in Crow-Fukase syndrome. ( Gohma, I; Hatta, K; Imanaka, T; Okura, H, 1995) |
| "Prednisolone therapy was effective but chest pain reappeared every morning when prednisolone was tapered to 30 mg alternate day." | 2.39 | Crow-Fukase syndrome: a case associated with vasospastic angina. ( Mochizuki, Y; Nozawa, K; Oishi, M; Sawada, S; Takasu, T; Uchiyama, T; Yoshihashi, H, 1994) |
| "POEMS syndrome is the syndrome of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein and typical Skin changes." | 1.46 | POEMS syndrome. ( Abdul Muttlib, FA; Abdul Wahid, SFS; Leong, CF; Masir, N; Nyunt, WWT; Remli, R; Tumian, NR, 2017) |
| "Echocardiography detected left ventricular hypertrophy and diastolic dysfunction." | 1.39 | Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome. ( Hisa, S; Kanno, Y; Kobayashi, A; Mizukami, H; Nakazato, K; Noji, H; Ogawa, K; Ohkawara, H; Saitoh, S; Shichishima-Nakamura, A; Suzuki, H; Takahashi, H; Takeishi, Y; Yokokawa, T; Yoshihisa, A, 2013) |
| "POEMS syndrome is a rare paraneoplastic condition associated to an underlying plasmacellular dyscrasia." | 1.38 | Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. ( Balducci, M; Chiusolo, P; De Stefano, V; Giannotta, C; Laurenti, L; Leone, G; Luigetti, M; Sabatelli, M; Sica, S; Sorà, F; Vannata, B, 2012) |
| "Glomeruloid hemangioma is a specific marker of POEMS syndrome and is related to Castleman's disease." | 1.35 | Glomeruloid hemangioma. ( Shikata, N; Takasu, K; Tsubura, A; Yamazaki, F; Yuri, T, 2008) |
| "The POEMS syndrome is a synopsis of different symptoms such as polyneuropathy, organomegaly, endocrine disturbances, M-protein and skin changes." | 1.29 | [POEMS syndrome: a contribution to differential diagnosis of polyneuropathy]. ( Dressnandt, J; Drosner, M; Klingelhöfer, J; Näher-Noé, M, 1993) |
| "We studied pathogenesis of hepatomegaly in Crow-Fukase syndrome." | 1.29 | [A study on the pathogenesis of hepatomegaly in patients with Crow-Fukase syndrome]. ( Fushimi, T; Inoue, A; Koh, CS; Yahikozawa, H; Yanagisawa, N, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (46.43) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nyunt, WWT | 1 |
| Remli, R | 1 |
| Abdul Muttlib, FA | 1 |
| Leong, CF | 1 |
| Masir, N | 1 |
| Tumian, NR | 1 |
| Abdul Wahid, SFS | 1 |
| Yokokawa, T | 1 |
| Nakazato, K | 1 |
| Kanno, Y | 1 |
| Mizukami, H | 1 |
| Kobayashi, A | 1 |
| Yoshihisa, A | 1 |
| Takahashi, H | 1 |
| Shichishima-Nakamura, A | 1 |
| Ohkawara, H | 1 |
| Noji, H | 1 |
| Suzuki, H | 1 |
| Saitoh, S | 1 |
| Ogawa, K | 2 |
| Hisa, S | 1 |
| Takeishi, Y | 1 |
| Kawamura, N | 1 |
| Kira, J | 1 |
| Paviour, DC | 1 |
| Ellis, CM | 1 |
| SASAKI, T | 1 |
| OHNISHI, S | 1 |
| ONISHI, R | 1 |
| TAKEMURA, R | 1 |
| KOBAYASHI, Y | 1 |
| SUZUKI, M | 1 |
| DAZAI, M | 1 |
| HATA, T | 1 |
| YAMAMOTO, J | 1 |
| ODA, H | 1 |
| TAKAHASHI, T | 1 |
| OGASAWARA, K | 1 |
| MIYAGISHIMA, T | 1 |
| Shimomura, Y | 1 |
| Hara, M | 1 |
| Mizote, I | 1 |
| Nakaoka, Y | 1 |
| Tanaka, H | 1 |
| Asano, Y | 1 |
| Sakata, Y | 1 |
| Komuro, I | 1 |
| Suyanı, E | 1 |
| Yağcı, M | 1 |
| Sucak, GT | 1 |
| Vannata, B | 1 |
| Laurenti, L | 1 |
| Chiusolo, P | 1 |
| Sorà, F | 1 |
| Balducci, M | 1 |
| Sabatelli, M | 1 |
| Luigetti, M | 1 |
| Giannotta, C | 1 |
| De Stefano, V | 1 |
| Leone, G | 1 |
| Sica, S | 1 |
| Sternberg, AJ | 1 |
| Davies, P | 1 |
| Macmillan, C | 1 |
| Abdul-Cader, A | 1 |
| Swart, S | 1 |
| Wiesmann, A | 1 |
| Weissert, R | 1 |
| Kanz, L | 1 |
| Einsele, H | 1 |
| Mukerjee, D | 1 |
| Kingdon, E | 1 |
| Vanderpump, M | 1 |
| Coghlan, JG | 1 |
| Chan, PT | 1 |
| Lee, KC | 1 |
| Chong, LY | 1 |
| Lo, KK | 1 |
| Cheung, YF | 1 |
| Kamezaki, K | 1 |
| Nagafuji, K | 1 |
| Yuri, T | 1 |
| Yamazaki, F | 1 |
| Takasu, K | 1 |
| Shikata, N | 1 |
| Tsubura, A | 1 |
| Okura, H | 1 |
| Gohma, I | 1 |
| Hatta, K | 1 |
| Imanaka, T | 1 |
| Mochizuki, Y | 1 |
| Yoshihashi, H | 1 |
| Oishi, M | 1 |
| Takasu, T | 1 |
| Nozawa, K | 1 |
| Uchiyama, T | 1 |
| Sawada, S | 1 |
| Vogelmeier, C | 1 |
| Biedermann, T | 1 |
| Gerth, A | 1 |
| Witthaut, R | 1 |
| Samtleben, W | 1 |
| Heuck, A | 1 |
| Steinbeck, G | 1 |
| Nanki, T | 1 |
| Tomiyama, J | 1 |
| Arai, S | 1 |
| Iwasaki, H | 1 |
| Yoshida, H | 2 |
| Takashima, F | 1 |
| Shimizu, K | 1 |
| Lee, JD | 1 |
| Ueda, T | 1 |
| Nakamura, T | 1 |
| Dressnandt, J | 1 |
| Näher-Noé, M | 1 |
| Drosner, M | 1 |
| Klingelhöfer, J | 1 |
| Takano, T | 1 |
| Tsujino, S | 1 |
| Higashihara, M | 1 |
| Nozaka, K | 1 |
| Kaneko, Y | 1 |
| Watanabe, T | 1 |
| Kurokawa, K | 1 |
| Fushimi, T | 1 |
| Inoue, A | 1 |
| Koh, CS | 1 |
| Yahikozawa, H | 1 |
| Yanagisawa, N | 1 |
| Saida, K | 2 |
| Kawakami, H | 1 |
| Ohta, M | 1 |
| Iwamura, K | 1 |
| Kuwabara, S | 1 |
| Hattori, T | 1 |
| Shimoe, Y | 1 |
| Kamitsukasa, I | 1 |
| Arimura, H | 1 |
| Watanabe, O | 1 |
| Arimura, K | 2 |
| Maruyama, I | 1 |
| Hokezu, Y | 1 |
| Okubo, R | 1 |
| Yoshida, T | 1 |
| Kimura, T | 1 |
| Okuma, K | 1 |
| Morioka, E | 1 |
| Kuno, S | 1 |
| Tamura, K | 1 |
| Suzumiya, A | 1 |
| Tsuboi, Y | 1 |
| Niimi, H | 1 |
| Jonosono, M | 1 |
| Hashiguchi, T | 1 |
| Kawabata, M | 1 |
| Osame, M | 1 |
| Kitajima, I | 1 |
3 reviews available for prednisolone and POEMS Syndrome
| Article | Year |
|---|---|
[Treatment strategy for POEMS syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Com | 2008 |
[POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers; Diagnosis, Diffe | 2007 |
Crow-Fukase syndrome: a case associated with vasospastic angina.
Topics: Acetylcholine; Angina Pectoris, Variant; Humans; Isosorbide Dinitrate; Male; Middle Aged; POEMS Synd | 1994 |
25 other studies available for prednisolone and POEMS Syndrome
| Article | Year |
|---|---|
POEMS syndrome.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Melphalan; Myeloablative Agonists; POEMS Syndrome; P | 2017 |
Pulmonary hypertension and refractory heart failure in a patient with Crow-Fukase (POEMS) syndrome.
Topics: Aged; Dexamethasone; Diuretics; Drug Resistance; Edema; Furosemide; Heart Failure; Humans; Hypertens | 2013 |
Paroxysmal hemicrania and POEMS syndrome: further evidence that neuropeptides are implicated in primary headache?
Topics: Adult; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 2008 |
POEMS syndrome complicated by follicular lymphoma.
Topics: Biomarkers; Biopsy; Fatal Outcome; Female; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; P | 2009 |
Sildenafil and steroid therapy effectively improved POEMS syndrome-associated pulmonary arterial hypertension.
Topics: Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Glucocorticoids; Humans; Hyperte | 2010 |
Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, N | 2011 |
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined | 2012 |
Strontium-89: a novel treatment for a case of osteosclerotic myeloma associated with life-threatening neuropathy.
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Disease Progression; Humans; Male; Middle Aged; | 2002 |
Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation.
Topics: Adult; Combined Modality Therapy; Drug Therapy, Combination; Humans; Ifosfamide; Melphalan; POEMS Sy | 2002 |
Pathophysiological insights from a case of reversible pulmonary arterial hypertension.
Topics: Azathioprine; Echocardiography; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Male; Mid | 2003 |
Glomeruloid haemangioma with cerebriform morphology in a patient with POEMS syndrome.
Topics: Adult; Antineoplastic Agents, Alkylating; Cyclophosphamide; Drug Therapy, Combination; Hemangioma; H | 2006 |
Glomeruloid hemangioma.
Topics: Biomarkers, Tumor; Castleman Disease; Female; Hemangioma; Humans; Lymph Nodes; Middle Aged; Parotid | 2008 |
Thiamine deficiency and pulmonary hypertension in Crow-Fukase syndrome.
Topics: Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Middle Aged; POEMS Syndrome; Pre | 1995 |
[45-year-old patient with hepatosplenomegaly, polyneuropathy and M-gradient].
Topics: Combined Modality Therapy; Diagnosis, Differential; Diagnostic Tests, Routine; Humans; Male; Middle | 1994 |
Mixed connective tissue disease associated with multicentric Castleman's disease.
Topics: Castleman Disease; Female; HLA-DR4 Antigen; Humans; Interleukin-6; Middle Aged; Mixed Connective Tis | 1994 |
Crow-Fukase syndrome associated with pulmonary hypertension.
Topics: Bone Marrow; Dyspnea; Edema; Empty Sella Syndrome; Female; Heart Failure; Humans; Hypertension, Pulm | 1993 |
[POEMS syndrome: a contribution to differential diagnosis of polyneuropathy].
Topics: Aged; Biopsy; Electromagnetic Fields; Electromyography; Female; Humans; Immunoglobulin E; Muscles; N | 1993 |
[Fatal case of Crow-Fukase syndrome with kidney failure, acute consciousness disorder and thrombocytopenia].
Topics: Acute Disease; Anti-Inflammatory Agents; Consciousness Disorders; Fatal Outcome; Glomerulonephritis, | 1995 |
[A study on the pathogenesis of hepatomegaly in patients with Crow-Fukase syndrome].
Topics: Aged; Animals; Anti-Inflammatory Agents; Ascitic Fluid; Cell Division; Cells, Cultured; Female; Hepa | 1996 |
Coagulation and vascular abnormalities in Crow-Fukase syndrome.
Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Axons; Biopsy; Blood Coagulation Fac | 1997 |
Long term melphalan-prednisolone chemotherapy for POEMS syndrome.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Drug Therapy, Combination; | 1997 |
[Two cases of POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Dexamethasone; Endothelial Growth Factors; Humans; Lymp | 1997 |
[Case of systemic Castleman's disease with hypothyroidism].
Topics: Anti-Inflammatory Agents; Castleman Disease; Cyclophosphamide; Female; Humans; Hypothyroidism; Immun | 1999 |
VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome.
Topics: Cytokines; Endothelial Growth Factors; Female; Humans; Hypertension, Pulmonary; Immunosuppressive Ag | 2000 |
[Application of adrenal cortex steroid hormone therapy and the associated problems].
Topics: Churg-Strauss Syndrome; Humans; Paraproteinemias; Peripheral Nervous System Diseases; POEMS Syndrome | 1992 |